Skip to content

ETPB in the News

Science News

Ketamine Lifts Depression Via a Byproduct of its Metabolism
May 4, 2016 • Press Release

NIH Nearly Doubles Investment in BRAIN Initiative Research
October 13, 2016 • Press Release

Rapid Agent Restores Pleasure-seeking Ahead of Other Antidepressant Action
October 17, 2014 • Press Release

Imaging Biomarker Predicts Response to Rapid Antidepressant: Signals Dysfunction in Brain System Targeted by Scopolamine: Maura Furey on Scopolamine Research
February 4, 2013 • Press Release

Webinar on Ketamine and Next Generation Therapies Featuring NIMH’s Carlos A. Zarate, M.D.
August 6, 2013• Science Update

Brain Signal ID's Responders to Fast-Acting Antidepressant: Biomarkers Help Pinpoint Mechanisms, Predict Outcomes
August 3, 2012 • News Release

Experimental Agent Briefly Eases Depression Rapidly in Test
December 11, 2012 • Press Release

Rapid Antidepressant Action of Common Medication Confirmed by Repeat Trial: Maura Furey on Scopolamine Research
May 4, 2010• Science Update

Study Shows Possibilities for Predicting How Patients Will Respond to Antidepressants
July 22, 2010 • Science Update

Experimental Medication Lifts Depression Symptoms in Bipolar Disorder Within an Hour
August 6, 2010• Science Update

Millisecond Brain Signals Predict Response to Fast-Acting Antidepressant: Electromagnetic Biomarker Could Minimize Trial-and-Error Prescribing
October 2, 2008 • Press Release

Research Highlights

Depression

The need for speed: A new approach to treating depressive disorders
NIH Intramural Research Program Research

From Despair to Hope in Hours
NIH Intramural Research Program Research in Action

Ketamine: A New (and Faster) Path to Treating Depression
NIMH Strategic Plan Highlight

Depression Research: Relief in Hours?
Summer 2007 Issue • MedlinePlus

Brain Scans Give Clues to Antidepressant's Effects
NIH News in Health

Bipolar Disorder

Major Ups and Downs: Bipolar Disorder Brings Extreme Mood Swings
NIH News in Health

Multimedia

Astute Clinician Lecture: “Relief from severe depression and suicidal ideation within hours: from synapses to symptoms” [Nov 24, 2015]

Ketamine and Depression: From Despair to Hope in Hours: Carlos Zarate, NIH Clinician Scientist [Apr 4, 2013]

Webinars

NIMH
Depression and TMS, Bruce Luber, PhD.,
American Academy for the Advancement of Science

Between Thought and Therapy: Translating Neurobiology Research into Treatments

Media Interviews

Depression Treatments Inspired By Club Drug Move Ahead In Tests
NPR, May 28, 2015

The Search for a 'Safer' Ketamine  -- Can glutamate drugs treat the worst cases of depression -- and keep pharma in psychiatry?
MEDPAGE Today, Nov 2, 2015

Brain Study Seeks Roots of Suicide
Scientific American, Nature: Mind, November 25, 2015

Ketamine and Next Generation Therapies - Carlos Zarate, M.D.
Brain & Behavior Research Foundation, August 14, 2013

Could A Club Drug Offer 'Almost Immediate' Relief From Depression? [Part 1]
NPR Morning Edition, January 30, 2012

'I Wanted To Live': New Depression Drugs Offer Hope For Toughest Cases [Part 2]
NPR Morning Edition, January 31, 2012

Ketamine Relieves Bipolar Depression, Suicidal Thoughts in Less Than an Hour
PsychCentral, May 31, 2012

Carlos Zarate MD, 2011 Bipolar Mood Disorders Prize
Brain & Behavior Research Foundation, November 15, 2011

Breast Cancer Med Reduces Mania
PsychCentral, September 12, 2007